
Ligand Pharmaceuticals (LGND) stock jumps premarket as BofA starts its coverage with a Buy rating and a $244 target, citing its business model. Read more here. Ligand gains new Buy from BofA on high-m...
Ligand Pharmaceuticals (LGND) stock jumps premarket as BofA starts its coverage with a Buy rating and a $244 target, citing its business model. Read more here. Ligand gains new Buy from BofA on high-m...